van der Wekken-Pas, Lena, Nassiwa, Sylvia, Malaba, Thokozule, Lamorde, Mohammed, Myer, Landon, Waitt, Catriona 
ORCID: 0000-0003-0134-5855, Reynolds, Helen ORCID: 0000-0001-7443-4520, Khoo, Saye, He, Nengjie, van Leeuwen, Liesbeth et al (show 3 more authors)
(2024)
Comparison of dolutegravir- and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV; a DolPHIN2 substudy.
AIDS (London, England).
|
Text
Author accepted Manuscript revised clean.pdf - Author Accepted Manuscript Download (201kB) | Preview |
Abstract
<h4>Background</h4>Both dolutegravir and efavirenz are known to be effective in pregnancy and post-partum to prevent vertical transmission of HIV and to maintain maternal health. Both drugs have also been associated with neuropsychiatric symptoms. To what extent these symptoms occur in pregnant and post-partum women, however, is not yet known.<h4>Methods</h4>This was a secondary analysis of the DolPHIN2 study, a multicenter randomized trial among women presenting late in pregnancy with untreated HIV- who received either a dolutegravir- or efavirenz- containing regimen. Longitudinal measures of depression, anxiety and sleep quality were analyzed during pregnancy and up to 48 weeks post-partum.<h4>Results</h4>Among 268 women median (IQR) Edinburgh Post Natal depression score (EPDS) scores were 8 (3-11) and highest at enrolment. In the dolutegravir -and efavirenz arm, respectively, 23.7% and 25.6% had an EPDS score above 9, indicating possible or probable depression. Abnormal Hospital Anxiety Depression scores (HADS) (above 11) were seen at least once during follow up in 42 of patients (15.7%), although no differences were seen between treatment arms. No association was found between EPDS, suicidality and HADS scores and the assigned regimen (p = 0.93, 0.97 and 0.18 respectively). Median (IQR) Pittsburgh Sleep Quality index (PSQI) scores for dolutegravir- and efavirenz were 6 (5-7) and 5 (5-6.5) respectively, p = 0.70.<h4>Conclusions</h4>No statistically significant differences were observed between efavirenz- or dolutegravir containing regimens. Rates of depression were high, but decreased over the course of time and confirm the need for psychological support after initial HIV diagnosis in pregnancy.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Brain Disorders, Depression, Behavioral and Social Science, Clinical Research, Mental Health, 6 Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Reproductive health and childbirth, Mental health, 3 Good Health and Well Being |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 12 Feb 2024 11:18 |
| Last Modified: | 25 Apr 2024 19:48 |
| DOI: | 10.1097/qad.0000000000003852 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3178392 |
Dimensions
Dimensions
